Header Logo

Connection

MICHAEL VOLK to Treatment Outcome

Back to Details
This is a "connection" page, showing publications MICHAEL VOLK has written about Treatment Outcome.
MICHAEL VOLK
Connection Strength
0.442
Treatment Outcome
  1. Positron Emission Tomography Scan in Detecting and Locating Extrahepatic Recurrent Hepatocellular Carcinoma Post Orthotic Liver Transplant. Prog Transplant. 2020 12; 30(4):396-397.
    View in: PubMed
    Score: 0.056
  2. Ruptured Hepatocellular Carcinoma following Transarterial Radioembolization. J Vasc Interv Radiol. 2018 09; 29(9):1302-1305.
    View in: PubMed
    Score: 0.049
  3. Transplantation for Alcohol-related Liver Disease: Is It Fair? Alcohol Alcohol. 2018 Mar 01; 53(2):173-177.
    View in: PubMed
    Score: 0.047
  4. The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year. Transplantation. 2017 07; 101(7):1666-1669.
    View in: PubMed
    Score: 0.045
  5. Pilot test of a patient decision aid about liver transplant organ quality. Liver Transpl. 2014 Jul; 20(7):850-5.
    View in: PubMed
    Score: 0.036
  6. Organ quality and quality of life after liver transplantation. Liver Transpl. 2011 Dec; 17(12):1443-7.
    View in: PubMed
    Score: 0.030
  7. Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant. 2009 Sep; 9(9):2113-8.
    View in: PubMed
    Score: 0.026
  8. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008 Nov; 135(5):1568-74.
    View in: PubMed
    Score: 0.025
  9. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant. 2008 Apr; 8(4):839-46.
    View in: PubMed
    Score: 0.023
  10. Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial. Cancer. 2023 11 15; 129(22):3554-3563.
    View in: PubMed
    Score: 0.017
  11. Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse. Liver Int. 2021 05; 41(5):1012-1019.
    View in: PubMed
    Score: 0.014
  12. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
    View in: PubMed
    Score: 0.013
  13. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver?Transplantation. Gastroenterology. 2019 Apr; 156(5):1381-1391.e3.
    View in: PubMed
    Score: 0.012
  14. Controversies in early liver transplantation for severe alcoholic hepatitis. Ann Hepatol. 2018 Aug 24; 17(5):759-768.
    View in: PubMed
    Score: 0.012
  15. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
    View in: PubMed
    Score: 0.011
  16. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol. 2015 Mar; 62(3):617-24.
    View in: PubMed
    Score: 0.009
  17. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl. 2014 Jan; 20(1):81-8.
    View in: PubMed
    Score: 0.009
  18. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. 2010 Jan; 51(1):165-73.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.